These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14730652)

  • 1. Bringing new treatments to the bedside in cystic fibrosis.
    Brennan AL; Geddes DM
    Pediatr Pulmonol; 2004 Feb; 37(2):87-98. PubMed ID: 14730652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging therapies in cystic fibrosis.
    Anderson P
    Ther Adv Respir Dis; 2010 Jun; 4(3):177-85. PubMed ID: 20530065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development?
    Burkhardt O; Lehmann C; Madabushi R; Kumar V; Derendorf H; Welte T
    J Antimicrob Chemother; 2006 Oct; 58(4):822-9. PubMed ID: 16885180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic fibrosis: looking for another breakthrough.
    Tecnologica; 1998 Feb; ():1, 3-6, 15. PubMed ID: 10182430
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulmonary infection in mild variant cystic fibrosis: implications for care.
    Lording A; McGaw J; Dalton A; Beal G; Everard M; Taylor CJ
    J Cyst Fibros; 2006 May; 5(2):101-4. PubMed ID: 16426904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for cystic fibrosis.
    Davies JC; Geddes DM; Alton EW
    J Gene Med; 2001; 3(5):409-17. PubMed ID: 11601754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobramycin for nebulisation: new formulation. A high price for a small improvement in formulation.
    Prescrire Int; 2002 Dec; 11(62):177-8. PubMed ID: 12469696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-Pseudomonas aerosol therapy in cystic fibrosis: improvement with tobramycin].
    Foucaud P; Borel B; Charara O; Nathanson S; Petitprez P; Pin I
    Rev Pneumol Clin; 2002 Jun; 58(3 Pt 1):131-8. PubMed ID: 12486796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New concepts of pathophysiology and therapy in cystic fibrosis].
    Hirche TO; Loitsch S; Smaczny C; Wagner TO
    Pneumologie; 2005 Nov; 59(11):811-8. PubMed ID: 16385442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open follow-up study of tobramycin nebuliser solution and colistin in patients with cystic fibrosis.
    Adeboyeku D; Scott S; Hodson ME
    J Cyst Fibros; 2006 Dec; 5(4):261-3. PubMed ID: 16807142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid pulmonary delivery of inhaled tobramycin for Pseudomonas infection in cystic fibrosis: a pilot project.
    Coates AL; Green M; Leung K; Chan J; Ribeiro N; Louca E; Ratjen F; Charron M; Tservistas M; Keller M
    Pediatr Pulmonol; 2008 Aug; 43(8):753-9. PubMed ID: 18613006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New pulmonary therapies for cystic fibrosis.
    Ratjen F
    Curr Opin Pulm Med; 2007 Nov; 13(6):541-6. PubMed ID: 17901762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in cystic fibrosis therapies.
    Rowe SM; Clancy JP
    Curr Opin Pediatr; 2006 Dec; 18(6):604-13. PubMed ID: 17099358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular targeting of CFTR as a therapeutic approach to cystic fibrosis.
    Amaral MD; Kunzelmann K
    Trends Pharmacol Sci; 2007 Jul; 28(7):334-41. PubMed ID: 17573123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis.
    Hazinski TA
    J Pediatr; 1999 Jul; 135(1):130. PubMed ID: 10428654
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutics development for cystic fibrosis: a successful model for a multisystem genetic disease.
    Ashlock MA; Olson ER
    Annu Rev Med; 2011; 62():107-25. PubMed ID: 21226613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New and investigational treatments in cystic fibrosis.
    Narasimhan M; Cohen R
    Ther Adv Respir Dis; 2011 Aug; 5(4):275-82. PubMed ID: 21372122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sputum antibiotic concentrations: implications for treatment of cystic fibrosis lung infection.
    Moriarty TF; McElnay JC; Elborn JS; Tunney MM
    Pediatr Pulmonol; 2007 Nov; 42(11):1008-17. PubMed ID: 17902147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modifier genes and cystic fibrosis].
    Corvol H; Flamant C; Vallet C; Clement A; Brouard J
    Arch Pediatr; 2006 Jan; 13(1):57-63. PubMed ID: 16274977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.